The Gut Microbiome and Cardiovascular Disease

Area of Science:

• Microbiology
• Cardiology
• Gastroenterology

Background:

• Cardiovascular disease (CVD) is the leading global cause of mortality.
• Emerging research links gut microbiome dysbiosis to CVD development.
• Gut bacteria produce metabolites that influence host health and disease.

Purpose of the Study:

• To review and synthesize current evidence on the gut microbiome's role in CVD.
• To explore the potential of microbiome modification as a therapeutic approach for CVD.

Main Methods:

• Literature review and critical analysis of existing studies.
• Consolidation of information on gut bacteria, metabolites, and CVD risk factors.

Main Results:

• Gut dysbiosis leads to increased production of trimethylamine-N-oxide (TMAO) from dietary components.
• Elevated TMAO levels are associated with increased risk of atherosclerosis, myocardial infarction, thrombosis, and stroke.
• Short-chain fatty acids (SCFAs) produced by beneficial bacteria have positive health effects.

Conclusions:

• The gut microbiome is a significant factor in cardiovascular health.
• Targeting gut dysbiosis and TMAO production presents a potential therapeutic avenue for CVD.
• Further research is warranted to establish microbiome modification as a clinical strategy.